← Open Payments lookup

JENNIFER GREENHECK: Open Payments

NPI 1396871158 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$7,506 in 106 payments from 18 companies in 2025. Trend: 2023 $1,193 · 2024 $5,313 · 2025 $7,506

Consulting: $3,384Food & beverage: $2,941Travel & lodging: $1,181
CompanyPaymentsAmount
GENZYME CORPORATION22$5,239
AstraZeneca Pharmaceuticals LP15$526
GlaxoSmithKline, LLC.26$473
Regeneron Healthcare Solutions, Inc.13$457
Verona Pharma, Inc.8$251
Boehringer Ingelheim Pharmaceuticals, Inc.3$148
Insmed, Inc.4$79
ANI Pharmaceuticals, Inc.2$50
Viatris Specialty LLC2$43
Calliditas Therapeutics US Inc.2$41

Products named: DUPIXENT, FASENRA, NUCALA, Ohtuvayre, TRELEGY ELLIPTA, BREZTRI, Arikayce, TEZSPIRE.

Industry payments across LA — which companies pay providers there.